Tourmaline Bio, Inc. (TRML) Total Assets by Year
Tourmaline Bio, Inc. closed fiscal year 2024 with $309.0M in total assets, $8.9M in total liabilities and $300.1M in shareholder equity. This represents an increase of 46.9% from the prior fiscal year. The table below carries 5 fiscal years, from 2020 to 2024, and the quarters Tourmaline Bio, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
TRML Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TRML Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2510-Q | Q1'2510-Q | Q4'2410-Q | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q | Q2'2310-Q | Q1'2310-Q | Q4'2210-K | Q3'2210-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $269.3M-21.9% | $287.5M-20.0% | $309.0M+46.9% | $328.4M+117.4% | $344.8M+116.7% | $359.2M+108.1% | $210.3M+2211.4% | $151.1M-26.9% | $159.1M-28.0% | $172.6M-27.2% | $9.1M-96.4% | $206.5M-21.0% |
| Total Liabilities | $10.1M+55.2% | $7.6M+51.8% | $8.9M+70.4% | $7.4M-96.3% | $6.5M-96.8% | $5.0M-97.5% | $5.3M-81.8% | $198.5M+1599.6% | $201.7M+1882.0% | $199.4M+1678.2% | $28.8M-88.5% | $11.7M+105.7% |
| Total Equity | $259.2M-23.4% | $279.9M-21.0% | $300.1M+46.3% | $321.1M+777.3% | $338.3M+895.4% | $354.2M+1419.5% | $205.0M+1139.1% | -$47.4M-124.3% | -$42.5M-120.2% | -$26.8M-111.9% | -$19.7M-8631.0% | $194.9M-23.8% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Tourmaline Bio, Inc. financials
Frequently Asked Questions
What was Tourmaline Bio, Inc.'s total assets in fiscal year 2024?
Tourmaline Bio, Inc. closed fiscal year 2024 with $309.0M in total assets, $8.9M in total liabilities and $300.1M in shareholder equity.
How fast is Tourmaline Bio, Inc.'s total assets growing?
Tourmaline Bio, Inc. (TRML) total assets rose by 46.9% year over year, from $210.3M to $309.0M in fiscal year 2024.
How has Tourmaline Bio, Inc.'s total assets changed over the years?
Across the 5 fiscal years this page covers, Tourmaline Bio, Inc. (TRML) total assets went from $152.8M in fiscal year 2020 to $309.0M in fiscal year 2024.
What was Tourmaline Bio, Inc.'s total assets in the most recent quarter?
Tourmaline Bio, Inc. (TRML) reported $269.3M in total assets in Q2 2025. This represents a decrease of 21.9% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Tourmaline Bio, Inc. (TRML) reported on that line in every period on record.